Form 8-K - Current report:
SEC Accession No. 0001193125-24-181655
Filing Date
2024-07-19
Accepted
2024-07-19 16:16:02
Documents
13
Period of Report
2024-07-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d874093d8k.htm   iXBRL 8-K 27381
  Complete submission text file 0001193125-24-181655.txt   154721

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bvs-20240719.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20240719_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20240719_pre.xml EX-101.PRE 11711
15 EXTRACTED XBRL INSTANCE DOCUMENT d874093d8k_htm.xml XML 3770
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 241127965
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)